PAR DRUGS AND CHEMICALS
Back to Balance Sheet
|
PAR DRUGS AND CHEMICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹3.85 Cr | ₹3.54 Cr | ₹3.64 Cr | ₹3.96 Cr | ₹8.19 Cr |
What is the latest Total Non-Current Liabilities ratio of PAR DRUGS AND CHEMICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹3.85 Cr |
| Mar2024 | ₹3.54 Cr |
| Mar2023 | ₹3.64 Cr |
| Mar2022 | ₹3.96 Cr |
| Mar2021 | ₹8.19 Cr |
How is Total Non-Current Liabilities of PAR DRUGS AND CHEMICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.85 Cr | 8.67 | |
| Mar2024 | ₹3.54 Cr | -2.75 | |
| Mar2023 | ₹3.64 Cr | -7.99 | |
| Mar2022 | ₹3.96 Cr | -51.70 | |
| Mar2021 | ₹8.19 Cr | - | |
Compare Total Non-Current Liabilities of peers of PAR DRUGS AND CHEMICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PAR DRUGS AND CHEMICALS | ₹111.0 Cr | 8.4% | -0.9% | -9.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.4% | 6.4% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -0.9% | 5% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 1.6% | 7.6% | 38.5% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.2% | 7.7% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.1% | -1.2% | 8.7% | Stock Analytics | |
PAR DRUGS AND CHEMICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PAR DRUGS AND CHEMICALS | 8.4% |
-0.9% |
-9.3% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses